Avonex Pen Interactions
There are 339 drugs known to interact with Avonex Pen (interferon beta-1a), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 14 are major, 324 are moderate, and 1 is minor.
- View all 339 medications that may interact with Avonex Pen
- View Avonex Pen alcohol/food interactions (1)
- View Avonex Pen disease interactions (4)
Most frequently checked interactions
View interaction reports for Avonex Pen (interferon beta-1a) and the medicines listed below.
- amantadine
- amitriptyline
- amlodipine
- Ampyra (dalfampridine)
- atorvastatin
- baclofen
- Calcium 600 D (calcium / vitamin d)
- cyclobenzaprine
- Cymbalta (duloxetine)
- dalfampridine
- duloxetine
- fenofibrate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- fluticasone nasal
- gabapentin
- Gilenya (fingolimod)
- hydrochlorothiazide
- ibuprofen
- levothyroxine
- Lyrica (pregabalin)
- melatonin
- modafinil
- multivitamin
- omeprazole
- oxybutynin
- tizanidine
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Avonex Pen alcohol/food interactions
There is 1 alcohol/food interaction with Avonex Pen (interferon beta-1a).
Avonex Pen disease interactions
There are 4 disease interactions with Avonex Pen (interferon beta-1a) which include:
Report options
QR code containing a link to this page
More about Avonex Pen (interferon beta-1a)
- Avonex Pen consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (14)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interferons
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.